APOE ε4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain

Masters, 2015, Alzheimer's disease, Nat Rev Dis Prim, 1, 1 Bertram, 2010, Schjeide LMS, AlzGene Belloy, 2019, A quarter century of APOE and Alzheimer's disease: progress to date and the path forward, Neuron, 101, 820, 10.1016/j.neuron.2019.01.056 Sweigart, 2021, APOE E2/E2 is associated with slower rate of cognitive decline with age, J Alzheimer's Dis, 83, 853, 10.3233/JAD-201205 Shinohara, 2020, Apoe2 is associated with longevity independent of alzheimer's disease, Elife, 9, 1, 10.7554/eLife.62199 Reiman, 2020, Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study, Nat Commun, 11, 667, 10.1038/s41467-019-14279-8 McKhann, 2011, The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's Dement, 7, 263, 10.1016/j.jalz.2011.03.005 Veitch, 2019, Understanding disease progression and improving Alzheimer's disease clinical trials: recent highlights from the Alzheimer's Disease neuroimaging initiative, Alzheimer's Dement, 15, 106, 10.1016/j.jalz.2018.08.005 Kang, 2015, The Alzheimer's disease neuroimaging initiative 2 biomarker core: a review of progress and plans, Alzheimer's Dement, 11, 772, 10.1016/j.jalz.2015.05.003 Bjorkli, 2020, Bridging the gap between fluid biomarkers for Alzheimer's disease, model systems, and patients, Front Aging Neurosci, 12, 1 Drzezga, 2003, Cerebral metabolic changes accompanying conversion of mild cognitive impairment into alzheimer's disease: a PET follow-up study, Eur J Nucl Med Mol Imaging, 30, 1104, 10.1007/s00259-003-1194-1 Yassine, 2020, APOE alleles and diet in brain aging and Alzheimer's disease, Front Aging Neurosci, 12, 10.3389/fnagi.2020.00150 Cunnane, 2020, Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing, Nat Rev Drug Discov, 19, 609, 10.1038/s41573-020-0072-x Arbones-Mainar, 2016, Metabolic shifts toward fatty-acid usage and increased thermogenesis are associated with impaired adipogenesis in mice expressing human APOE4, Int J Obes, 40, 1574, 10.1038/ijo.2016.93 Wu, 2018, Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer's disease risk reduction and early intervention, J Neurosci, 38, 6665, 10.1523/JNEUROSCI.2262-17.2018 Guasch-Ferré, 2016, Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions, Am J Clin Nutr, 103, 1408, 10.3945/ajcn.116.130492 Guasch-Ferré, 2019, Plasma acylcarnitines and risk of type 2 diabetes in a mediterranean population at high cardiovascular risk, J Clin Endocrinol Metab, 104, 1508, 10.1210/jc.2018-01000 Rinaldo, 2008, Acylcarnitine profile analysis, Genet Med, 10, 151, 10.1097/GIM.0b013e3181614289 Ramsay, 2001, Molecular enzymology of carnitine transfer and transport, 21 Ramsay, 2004, Carnitine acyltransferases and their influence on CoA pools in health and disease, Mol Aspects Med, 25, 475, 10.1016/j.mam.2004.06.002 Westin, 2008, Short- and medium-chain carnitine acyltransferases and acyl-CoA thioesterases in mouse provide complementary systems for transport of β-oxidation products out of peroxisomes, Cell Mol Life Sci, 65, 982, 10.1007/s00018-008-7576-6 Wanders, 2006, Biochemistry of mammalian peroxisomes revisited, Annu Rev Biochem, 75, 295, 10.1146/annurev.biochem.74.082803.133329 Newgard, 2009, A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance, Cell Metab, 9, 311, 10.1016/j.cmet.2009.02.002 Inano, 2003, Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2, Biopharm Drug Dispos, 24, 357, 10.1002/bdd.371 Liepinsh, 2017, Carnitine and γ-butyrobetaine stimulate elimination of meldonium due to competition for OCTN2-mediated transport, Basic Clin Pharmacol Toxicol, 120, 450, 10.1111/bcpt.12729 Nałezcz, 2004, Carnitine: transport and physiological functions in the brain, Mol Aspects Med, 25, 551 Hajjar I, Cai Q, Yu T, Jones D. Untargeted metabolomics shows alterations in homocysteine, lipids and fatty acids predicting memory decline in healthy middle-aged individuals. 2020. Buawangpong, 2021, The role of trimethylamine-N-Oxide in the development of Alzheimer's disease, J Cell Physiol Qi, 2018, Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies, J Cell Mol Med, 22, 185, 10.1111/jcmm.13307 Lemaitre, 2021, Association of trimethylamine N-Oxide and related metabolites in plasma and incident type 2 diabetes: the cardiovascular health study, JAMA Netw Open, 4, 1, 10.1001/jamanetworkopen.2021.22844 2009, Alzheimer's disease anti-inflammatory prevention trial: design, methods, and baseline results, Alzheimer's Dement, 5, 93, 10.1016/j.jalz.2008.09.004 Lyketsos, 2007, Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial, Neurology, 68, 1800, 10.1212/01.wnl.0000260269.93245.d2 Wenham, 1991, Analysis of apolipoprotein E genotypes by the amplification refractory mutation system, Clin Chem, 37, 241, 10.1093/clinchem/37.2.241 McKhann, 1984, Clinical diagnosis of alzheimer's disease: Report of the NINCDS-ADRDA work group⋆ under the auspices of department of health and human services task force on alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 Petersen, 1997, Aging, memory, and mild cognitive impairment, Int Psychogeriatrics, 9, 65, 10.1017/S1041610297004717 Albert, 2011, The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's Dement, 7, 270, 10.1016/j.jalz.2011.03.008 Huguenard, 2020, Plasma lipidomic analyses in cohorts with mTBI and/or PTSD reveal lipids differentially associated with diagnosis and APOE ε4 carrier status, Front Physiol, 11, 10.3389/fphys.2020.00012 Bennett, 2012, Overview and findings from the religious orders study, Curr Alzheimer Res, 9, 628, 10.2174/156720512801322573 Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, Schneider JA. Religious orders study and rush memory and aging project. Perry G, Avila J, Moreira PI, Sorensen AA, Tabaton M, editors. J Alzheimer's Dis. 2018 Jun 12;64(s1):S161–89. Available from: https://www.medra.org/servlet/aliasResolver?alias=iospress&doi=10.3233/JAD-179939 Bennett, 2006, Decision rules guiding the clinical diagnosis of Alzheimer's Disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study, Neuroepidemiology, 27, 169, 10.1159/000096129 Moms, 1989, The consortium to establish a registry for Alzheimer's DIsease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease, Neurology, 39, 1159, 10.1212/WNL.39.9.1159 Braak, 1997, Consensus recommendations for the postmortem diagnosis of Alzheimer's disease, Neurobiol Aging, 18, S1, 10.1016/S0197-4580(97)00057-2 Braak, 1991, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol, 82, 239, 10.1007/BF00308809 Ciavardelli, 2016, Medium-chain plasma acylcarnitines, ketone levels, cognition, and gray matter volumes in healthy elderly, mildly cognitively impaired, or Alzheimer's disease subjects, Neurobiol Aging, 43, 1, 10.1016/j.neurobiolaging.2016.03.005 Le Foll, 2016, Fatty acid-induced astrocyte ketone production and the control of food intake, Am J Physiol - Regulatory Integr Compar Physiol, 310, R1186, 10.1152/ajpregu.00113.2016 Su, 2019, Plasmalogens and Alzheimer's disease: a review, Lipids Health Dis, 18, 100, 10.1186/s12944-019-1044-1 Pennisi, 2020, Acetyl-L-carnitine in dementia and other cognitive disorders: a critical update, Nutrients, 12, 1389, 10.3390/nu12051389 Lin, 2019, A metabolomic approach to identifying biomarkers in blood of Alzheimer's disease, Ann Clin Transl Neurol, 6, 537, 10.1002/acn3.726 Mapstone, 2017, What success can teach us about failure: the plasma metabolome of older adults with superior memory and lessons for Alzheimer's disease, Neurobiol Aging, 51, 148, 10.1016/j.neurobiolaging.2016.11.007 Griffin, 2017, Amino acid catabolism in Alzheimer's disease brain: friend or foe?, Oxid Med Cell Longev, 2017, 10.1155/2017/5472792 Huo, 2020, Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis, Neurobiol Aging, 86, 123, 10.1016/j.neurobiolaging.2019.10.014 Varma, 2018, Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study, PLoS Medicine, 15 Arrona Cardoza, 2021, Alzheimer's disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?, Nutr Rev, 00, 1 Carlos Rubio, 1998, Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease, J Neurol Sci, 155, 192, 10.1016/S0022-510X(97)00314-6 Lodeiro, 2014, Decreased cerebrospinal fluid levels of L-carnitine in non-apolipoprotein E4 carriers at early stages of Alzheimer's disease, J Alzheimer's Dis, 41, 223, 10.3233/JAD-132063 Makar, 1995, Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain, Neurochem Res, 20, 705, 10.1007/BF01705539 Toledo, 2017, Metabolic network failures in Alzheimer's disease: A biochemical road map, Alzheimers Dement, 13, 965, 10.1016/j.jalz.2017.01.020 Reuter, 2008, Determination of the reference range of endogenous plasma carnitines in healthy adults, Ann Clin Biochem, 45, 585, 10.1258/acb.2008.008045 Horber, 1997, Effect of sex and age on bone mass, body composition and fuel metabolism in humans, Nutrition, 13, 524, 10.1016/S0899-9007(97)00031-2 Santosa, 2015, The sexual dimorphism of lipid kinetics in humans, Front Endocrinol, 6, 1 Genuth, 1979, Plasma and urine carnitine in diabetic ketosis, Diabetes, 28, 1083, 10.2337/diab.28.12.1083 Schooneman, 2014, Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism, Biochim Biophys Acta - Mol Cell Biol Lipids, 1841, 987, 10.1016/j.bbalip.2014.04.001 Koeth, 2019, L-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans, J Clin Invest, 129, 373, 10.1172/JCI94601 Velden, 2013, Differences between acylcarnitine pro fi les in plasma and bloodspots, Mol Genet Metab, 6 Barnes, 2015, Dementia: Cognitive resilience in APOE*ε4 carriers—is race important?, Nat Rev Neurol, 11, 190, 10.1038/nrneurol.2015.38 Morris, 2019, Assessment of racial disparities in biomarkers for Alzheimer disease, JAMA Neurol, 76, 264, 10.1001/jamaneurol.2018.4249 Tang, 1998, The APOE-ε4 Allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics, JAMA, 279, 751, 10.1001/jama.279.10.751 Powell, 2021, The relationship of APOE ε4, race, and sex on the age of onset and risk of dementia, Frontiers in Neurology, 12, 10.3389/fneur.2021.735036 Adams, 2009, Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid β-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women, J Nutr, 139, 1073, 10.3945/jn.108.103754 Cristofano, 2016, Serum levels of acyl-carnitines along the continuum from normal to Alzheimer's dementia, PLoS One, 11, 1, 10.1371/journal.pone.0155694 Mapstone, 2014, Plasma phospholipids identify antecedent memory impairment in older adults, Nat Med, 20, 415, 10.1038/nm.3466 Van Der Velpen, 2019, Systemic and central nervous system metabolic alterations in Alzheimer's disease, Alzheimer's Res Ther, 11, 1, 10.1186/s13195-019-0551-7 González-Domínguez, 2014, Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry, Electrophoresis, 35, 3321, 10.1002/elps.201400196